Compare HLN & IBKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | IBKR |
|---|---|---|
| Founded | 2022 | 1977 |
| Country | United Kingdom | United States |
| Employees | N/A | 2998 |
| Industry | Package Goods/Cosmetics | Investment Bankers/Brokers/Service |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 36.2B |
| IPO Year | N/A | 2006 |
| Metric | HLN | IBKR |
|---|---|---|
| Price | $9.28 | $83.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $84.00 |
| AVG Volume (30 Days) | ★ 8.9M | 4.0M |
| Earning Date | 02-26-2026 | 04-21-2026 |
| Dividend Yield | ★ 1.94% | 0.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $2,580,000,000.00 |
| Revenue This Year | $6.55 | $12.51 |
| Revenue Next Year | $4.42 | $11.18 |
| P/E Ratio | ★ $49.05 | $141.93 |
| Revenue Growth | N/A | ★ 9.04 |
| 52 Week Low | $8.71 | $49.30 |
| 52 Week High | $11.42 | $214.14 |
| Indicator | HLN | IBKR |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 56.54 |
| Support Level | $9.26 | $60.89 |
| Resistance Level | $9.95 | N/A |
| Average True Range (ATR) | 0.14 | 2.37 |
| MACD | 0.04 | -0.33 |
| Stochastic Oscillator | 70.00 | 51.26 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Interactive Brokers is a large, automated, retail and institutional brokerage that boasted nearly $780 billion in customer equity at the end of 2025. The company cut its teeth as a market maker, introducing US financial markets to automated and algorithmic training before expanding into brokerage services in 1993. The firm has a wide-ranging client base, with its best-in-class order execution and extremely low margin lending rates catering to a sophisticated audience of hedge funds, proprietary traders, and introducing brokers that account for about 45% of the firm's commissions. With operations spanning more than 160 electronic exchanges, 36 countries, and 28 currencies, Interactive Brokers caters to a global clientele, with more than 80% of active accounts sitting outside the US.